Oral vancomycin is not associated with meaningful changes in liver-related endpoints among adults with primary sclerosing cholangitis: A randomized, placebo-controlled trial

American Journal of Gastroenterology · Published 2026-07-23 · DOI 10.14309/ajg.0000000000004135

Authors (11)

John E. Eaton, Mitchell W. Clayton, Denise M. Harnois, Duke J. Butterfield, Nan Zhang, Sudhakar K. Venkatesh, Nicholas V. Nguyen, Andrea A. Gossard, Keith D. Lindor, Nicholas F. LaRusso, Elizabeth J. Carey

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Eaton, J., Clayton, M., Harnois, D., et al. (2026). Oral vancomycin is not associated with meaningful changes in liver-related endpoints among adults with primary sclerosing cholangitis: A randomized, placebo-controlled trial. American Journal of Gastroenterology. https://doi.org/10.14309/ajg.0000000000004135

Related articles